Yutaka Igarashi1, Nobuhiko Akazawa2,3, Seiji Maeda3,4. 1. Osaka City University, Osaka, 558-8585, Japan. yu_igarashi_000@mail.goo.ne.jp. 2. Japan Institute of Sports Sciences, Tokyo, 115-0056, Japan. 3. Faculty of Health and Sport Sciences, University of Tsukuba, Ibaraki, 305-8574, Japan. 4. Faculty of Sport Sciences, Waseda University, Saitama, 359-1192, Japan.
Abstract
PURPOSE: The aim of the study was to evaluate the relationship between changes in hemoglobin A1c (HbA1c) and exercise levels in type 2 diabetes mellitus (T2DM) patients when performing various types of exercise. METHODS: The inclusion criteria were randomized controlled trials involving adults with T2DM, intervention involving exercise alone, the overall duration of intervention ≥12 weeks, and reporting HbA1c. Weighted mean difference (WMD) was defined as the mean difference between the intervention group and the control group weighted by the inverse of the squared standard error for each study, and all WMDs were pooled as overall effects. A meta-regression analysis was performed to evaluate the relationship between the exercise level and the WMD in HbA1c. RESULTS: Forty-eight studies (2395 subjects) were analyzed. The pooled WMD in HbA1c decreased significantly (-0.5% [95% confidence intervals: -0.6 to -0.4]) but contained significant heterogeneity (Q = 103.8, P < 0.01; I2 = 36.6%). A meta-regression analysis showed that the intensity (metabolic equivalents [METs]), time (min/session), or frequency (sessions/week) of the exercise was not associated with the HbA1c. However, the overall duration of exercise (weeks) was significantly associated with the WMD in HbA1c (meta-regression coefficient: 0.01 [95% confidence intervals: 0.002-0.016]; R2 = 70.0%), and that result did not contain significant heterogeneity (P > 0.05; I2 = 14.7%). CONCLUSIONS: The exercise intervention decreases HbA1c in T2DM patients. In addition, exercise for an extended duration was associated with an increase in HbA1c, so the effects of exercise may be evident early on, but results suggested that exercise for a prolonged period alone may increase HbA1c.
PURPOSE: The aim of the study was to evaluate the relationship between changes in hemoglobin A1c (HbA1c) and exercise levels in type 2 diabetes mellitus (T2DM) patients when performing various types of exercise. METHODS: The inclusion criteria were randomized controlled trials involving adults with T2DM, intervention involving exercise alone, the overall duration of intervention ≥12 weeks, and reporting HbA1c. Weighted mean difference (WMD) was defined as the mean difference between the intervention group and the control group weighted by the inverse of the squared standard error for each study, and all WMDs were pooled as overall effects. A meta-regression analysis was performed to evaluate the relationship between the exercise level and the WMD in HbA1c. RESULTS: Forty-eight studies (2395 subjects) were analyzed. The pooled WMD in HbA1c decreased significantly (-0.5% [95% confidence intervals: -0.6 to -0.4]) but contained significant heterogeneity (Q = 103.8, P < 0.01; I2 = 36.6%). A meta-regression analysis showed that the intensity (metabolic equivalents [METs]), time (min/session), or frequency (sessions/week) of the exercise was not associated with the HbA1c. However, the overall duration of exercise (weeks) was significantly associated with the WMD in HbA1c (meta-regression coefficient: 0.01 [95% confidence intervals: 0.002-0.016]; R2 = 70.0%), and that result did not contain significant heterogeneity (P > 0.05; I2 = 14.7%). CONCLUSIONS: The exercise intervention decreases HbA1c in T2DM patients. In addition, exercise for an extended duration was associated with an increase in HbA1c, so the effects of exercise may be evident early on, but results suggested that exercise for a prolonged period alone may increase HbA1c.
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: E G Wilmot; C L Edwardson; F A Achana; M J Davies; T Gorely; L J Gray; K Khunti; T Yates; S J H Biddle Journal: Diabetologia Date: 2012-08-14 Impact factor: 10.122
Authors: Craig J Currie; John R Peters; Aodán Tynan; Marc Evans; Robert J Heine; Oswaldo L Bracco; Tony Zagar; Chris D Poole Journal: Lancet Date: 2010-01-26 Impact factor: 79.321
Authors: Alison K Wright; Evangelos Kontopantelis; Richard Emsley; Iain Buchan; Mamas A Mamas; Naveed Sattar; Darren M Ashcroft; Martin K Rutter Journal: Circulation Date: 2019-04-15 Impact factor: 29.690
Authors: Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden Journal: Ann Intern Med Date: 2004-09-21 Impact factor: 25.391
Authors: Zhilei Shan; Yanping Li; Geng Zong; Yanjun Guo; Jun Li; JoAnn E Manson; Frank B Hu; Walter C Willett; Eva S Schernhammer; Shilpa N Bhupathiraju Journal: BMJ Date: 2018-11-21
Authors: Jason I Chiang; Peter Hanlon; Tsai-Chung Li; Bhautesh Dinesh Jani; Jo-Anne Manski-Nankervis; John Furler; Cheng-Chieh Lin; Shing-Yu Yang; Barbara I Nicholl; Sharmala Thuraisingam; Frances S Mair Journal: PLoS Med Date: 2020-05-07 Impact factor: 11.069